Application 065100
- Type
- ANDA
- Sponsor
- RANBAXY LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PANIXINE DISPERDOSE | CEPHALEXIN | TABLET, FOR SUSPENSION;ORAL | EQ 250MG BASE | No | No |
| 002 | PANIXINE DISPERDOSE | CEPHALEXIN | TABLET, FOR SUSPENSION;ORAL | EQ 125MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065100-001 | PANIXINE DISPERDOSE | CEPHALEXIN | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | ||
| A065100-002 | PANIXINE DISPERDOSE | CEPHALEXIN | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065100-001 | PANIXINE DISPERDOSE | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A065100-002 | PANIXINE DISPERDOSE | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A065100-001 | PANIXINE DISPERDOSE | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | f41ea6bd6efb… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A065100-002 | PANIXINE DISPERDOSE | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A065100-001 | PANIXINE DISPERDOSE | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | e64feba35796… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A065100-002 | PANIXINE DISPERDOSE | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A065100-001 | PANIXINE DISPERDOSE | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | cb3db0bc1861… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A065100-002 | PANIXINE DISPERDOSE | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A065100-001 | PANIXINE DISPERDOSE | EQ 250MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | a50c72e98297… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A065100-002 | PANIXINE DISPERDOSE | EQ 125MG BASE | TABLET, FOR SUSPENSION / ORAL | 2003-09-11 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 2506895d-f3e0-4be9-95cb-7a6fd44de46d | 2026-11-06 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 9fc5cfb0-7ba0-4669-b79c-270b6a9ff573 | 2026-10-29 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 681c235f-6dee-1401-e053-2991aa0addc0 | 2026-10-28 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | c0ca008e-0e28-412e-a58f-70f63817713b | 2026-10-23 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 7cbdfa7f-2ea0-48e1-b506-59f58e5685a6 | 2026-10-19 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 73920373-b45d-45d6-b183-d962467dde36 | 2026-10-19 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | 36882c6d-7b6f-41e3-8c54-e3b0073b8c07 | 2026-10-16 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Northwind Health Company, LLC | 4ecf9314-76e2-c270-e063-6294a90ad8db | 2026-10-16 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 8499aa5a-49b1-4555-bd27-6177d92b261d | 2026-10-15 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b3bb8222-161e-4d9c-8e08-7e22ad65bf72 | 2026-10-13 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b73593ce-0b1f-4371-bae1-140742de3b42 | 2026-10-12 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | bb28751c-bd1b-4e7f-8271-a14c1b4314e3 | 2026-10-12 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | f957ea27-2906-40c7-ac03-eb2f742473a0 | 2026-09-15 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | 8e28f049-6110-4473-830f-c494191a7197 | 2026-09-15 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | e54df878-c235-4aa3-af33-fe5287c73138 | 2026-09-14 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 1716ea1e-40a9-4a23-870b-3c7e3d070095 | 2026-09-14 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6c543819-ab98-1dcd-e053-2991aa0a109d | 2026-09-14 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 5858b90a-a80d-40b4-9275-b89e9121ea42 | 2026-09-02 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Lupin Pharmaceuticals, Inc. | 1d3e6d33-5dc2-498e-8efa-e3c4fca15dff | 2026-08-24 | Warnings, Adverse reactions | CEPHALEXIN |
| Cephalexin | CEPHALEXIN | HAWAII REPACK, INC. | d54abc0a-3c8f-4f02-bd55-406f0c5b925a | 2026-08-18 | Warnings, Adverse reactions | CEPHALEXIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 22312 | ORIG | 2005-07-22 |